(Reuters) -The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo Nordisk, special vouchers that will speed up the review of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback